Company news
North China Pharmaceutical Company Ltd. news in 2026
North China Pharmaceutical Company Ltd.'s news releases, calls and decks from 2026, newest first.
(600812)"North China Pharmaceutical Company Ltd."Notice on Convening the 1st Extraordinary General Meeting in 2026
November 5, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Resolutions of the 4th Meeting of the 12th Board of Directors
November 5, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Expansion of Business Scope and Amendment to the Articles of Association
November 5, 2026
(600812)"North China Pharmaceutical Company. Ltd."Announcement on Obtaining the Drug Registration Certificate by a Subsidiary
October 28, 2026
(600812)"North China Pharmaceutical Company Ltd."Report for Q3 2026
October 27, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Resolutions of the 3rd Meeting of the 12th Board of Directors
October 27, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Proposed Application for Unified Registration and Issuance of Debt Financing Instruments (PDFI)
October 27, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on External Investment through Equity Participation and Related Party Transaction
October 27, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Change in Accounting Policies
October 27, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Completion of Interest Payment for the First Tranche of Sci-Tech Innovation Bonds in 2025
October 26, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Obtaining Drug Registration Certificate
October 23, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Risk Warning in Stock Trading
October 12, 2026
(600812)"North China Pharmaceutical Company Ltd."Announcement on Abnormal Fluctuations in Stock Trading
October 9, 2026
Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Hebei Jurisdiction and 2026 Semi-annual Collective Performance Briefing
September 9, 2026
Announcement on Providing Guarantees for Subsidiaries
September 2, 2026
Announcement on Obtaining Notice of Approval for Drug Supplementary Application by a Subordinate Company
August 27, 2026
Semi-annual Report for 2026
August 21, 2026
Announcement on Resignation of Senior Management
August 5, 2026
Announcement on the Proposed Selection of Drugs of the Company and Its Subsidiaries in the National Centralized Drug Procurement
August 3, 2026
Announcement on Inclusion of Products of the Company and Its Subsidiaries in the National Essential Medicines List
July 10, 2026
Announcement on Obtaining Drug Registration Certificate
June 23, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 4, 2026
Announcement on Election of Employee Director
May 20, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 7, 2026
Announcement on Release of Pledge and Pledge of Some Shares of Shareholders
April 28, 2026
Notice on Convening the 2025 Annual General Meeting
April 24, 2026
Announcement on Renewing Engagement of Accounting Firm
April 17, 2026
Announcement on Receipt of Government Land Acquisition and Sale Proceeds Return Payments
April 3, 2026
Announcement on Obtaining the Drug Registration Certificate by Subsidiary
February 9, 2026
Announcement on Providing Guarantee for Subsidiary
February 2, 2026
Announcement on Wholly-owned Subsidiary's Passing GMP Compliance Inspection for Drugs
January 23, 2026